tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CELC Stock Latest News

Celcuity (CELC) Holds a Potential Game-changer in Cancer Treatment
Market NewsCelcuity (CELC) Holds a Potential Game-changer in Cancer Treatment
9d ago
CELC
Celcuity files $400M mixed securities shelf
PremiumThe Fly
Celcuity files $400M mixed securities shelf
20d ago
CELC
Celcuity initiated with an Outperform at LifeSci Capital
PremiumThe Fly
Celcuity initiated with an Outperform at LifeSci Capital
24d ago
CELC
Cisco, Walmart report quarterly earnings beats: Morning Buzz
PremiumThe Fly
Cisco, Walmart report quarterly earnings beats: Morning Buzz
1M ago
DE
JD
Celcuity price target lowered to $39 from $40 at Stifel
PremiumThe Fly
Celcuity price target lowered to $39 from $40 at Stifel
1M ago
CELC
Celcuity reports Q2 adjusted EPS (58c), consensus (68c)
PremiumThe FlyCelcuity reports Q2 adjusted EPS (58c), consensus (68c)
1M ago
CELC
Celcuity Inc. Reports Second Quarter Financial Results and Provides Corporate Update
Premium
Press Releases
Celcuity Inc. Reports Second Quarter Financial Results and Provides Corporate Update
1M ago
CELC
CELC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
CELC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
CELC
Celcuity Inc. Schedules Release of Second Quarter 2024 Financial Results and Webcast/Conference Call
PremiumPress Releases
Celcuity Inc. Schedules Release of Second Quarter 2024 Financial Results and Webcast/Conference Call
1M ago
CELC
Celcuity initiated with an Outperform at Leerink
PremiumThe Fly
Celcuity initiated with an Outperform at Leerink
2M ago
CELC
Celcuity To Participate in Jefferies Global Healthcare Conference
PremiumPress Releases
Celcuity To Participate in Jefferies Global Healthcare Conference
4M ago
CELC
Celcuity prices 3.87M shares at $15.50 in underwritten common stock offering
PremiumThe Fly
Celcuity prices 3.87M shares at $15.50 in underwritten common stock offering
4M ago
CELC
Celcuity Announces Pricing of Underwritten Common Stock Offering
PremiumPress ReleasesCelcuity Announces Pricing of Underwritten Common Stock Offering
4M ago
CELC
Celcuity Inc. Announces Plan to Initiate a Phase 3 Clinical Trial for Gedatolisib as First-Line Treatment for HR+/HER2- Advanced Breast Cancer and Secures Approximately $62 Million Debt Financing
Premium
Press Releases
Celcuity Inc. Announces Plan to Initiate a Phase 3 Clinical Trial for Gedatolisib as First-Line Treatment for HR+/HER2- Advanced Breast Cancer and Secures Approximately $62 Million Debt Financing
4M ago
CELC
Celcuity announces plans to initiate Phase 3 trial of gedatolisib
Premium
The Fly
Celcuity announces plans to initiate Phase 3 trial of gedatolisib
4M ago
CELC
Celcuity assumed with a Buy at Craig-Hallum
PremiumThe Fly
Celcuity assumed with a Buy at Craig-Hallum
4M ago
CELC
Celcuity Inc. Reports First Quarter Financial Results and Provides Corporate Update
PremiumPress Releases
Celcuity Inc. Reports First Quarter Financial Results and Provides Corporate Update
4M ago
CELC
Celcuity reports Q1 EPS (59c), consensus (71c)
PremiumThe Fly
Celcuity reports Q1 EPS (59c), consensus (71c)
4M ago
CELC
Celcuity Shareholders Approve Stock Plan Expansion and Elect Board
PremiumCompany Announcements
Celcuity Shareholders Approve Stock Plan Expansion and Elect Board
4M ago
8K
CELC
Is CELC a Buy, Before Earnings?
PremiumPre-EarningsIs CELC a Buy, Before Earnings?
4M ago
CELC
Celcuity Inc. Schedules Release of First Quarter 2024 Financial Results and Webcast/Conference Call
Premium
Press Releases
Celcuity Inc. Schedules Release of First Quarter 2024 Financial Results and Webcast/Conference Call
4M ago
CELC
Celcuity To Present at Upcoming Needham and Stifel Investor Conferences
Premium
Press Releases
Celcuity To Present at Upcoming Needham and Stifel Investor Conferences
6M ago
CELC

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >